Search research articles
Contact Us
Filters
Showing results (71-80 of 785) with videos related to
Page
of 79
Sort By:
Expert Review of Gastroenterology & Hepatology
|
January 27, 2016
Vedolizumab in the treatment of Crohn's disease
Dino Tarabar, Ayal Hirsch, David T Rubin
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique
|
December 14, 2004
When breastfeeding mothers need CNS-acting drugs
Evelyn T Rubin, Amy Lee, Shinya Ito
PLOS Mental Health
|
February 9, 2026
The puzzle of pain and its psychological implications: Differentiating complex regional pain syndrome from somatic symptom disorder
Paul D C Zimmer, Robert T Rubin
Intestinal Research
|
March 13, 2024
The evolving understanding of histology as an endpoint in ulcerative colitis
Shintaro Akiyama, Yusuke Miyatani, David T Rubin
Inflammatory Bowel Diseases
|
July 22, 2015
U.S. Patients with Ulcerative Colitis Do Not Have a Decreased Risk of Diverticulosis
Jami Kinnucan, Justin Tomal, David T Rubin
Gastroenterology & Hepatology
|
May 7, 2014
Ethical considerations for clinical trials in inflammatory bowel disease
David T Rubin, Samuel Becker, Mark Siegler
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
May 13, 2024
Impact of a health-system specialty pharmacy on time to upadacitinib initiation
David Choi, David T Rubin, Bernice Man
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 7, 2000
Temporal expression of the chondrogenic and angiogenic growth factor CYR61 during fracture repair
M Hadjiargyrou, W Ahrens, C T Rubin
Plos One
|
April 21, 2017
Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States
Haridarshan Patel, Trevor Lissoos, David T Rubin
Inflammatory Bowel Diseases
|
February 24, 2012
Response to biologic therapy in Crohn's disease is improved with early treatment: an analysis of health claims data
David T Rubin, Ozgecan Uluscu, Robert Sederman
Page
of 79
Search research articles
Search
Showing results (71-80 of 785) with videos related to
Sort By:
Page
of 79
Expert Review of Gastroenterology & Hepatology
|
January 27, 2016
Vedolizumab in the treatment of Crohn's disease
Dino Tarabar, Ayal Hirsch, David T Rubin
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique
|
December 14, 2004
When breastfeeding mothers need CNS-acting drugs
Evelyn T Rubin, Amy Lee, Shinya Ito
PLOS Mental Health
|
February 9, 2026
The puzzle of pain and its psychological implications: Differentiating complex regional pain syndrome from somatic symptom disorder
Paul D C Zimmer, Robert T Rubin
Intestinal Research
|
March 13, 2024
The evolving understanding of histology as an endpoint in ulcerative colitis
Shintaro Akiyama, Yusuke Miyatani, David T Rubin
Inflammatory Bowel Diseases
|
July 22, 2015
U.S. Patients with Ulcerative Colitis Do Not Have a Decreased Risk of Diverticulosis
Jami Kinnucan, Justin Tomal, David T Rubin
Gastroenterology & Hepatology
|
May 7, 2014
Ethical considerations for clinical trials in inflammatory bowel disease
David T Rubin, Samuel Becker, Mark Siegler
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
May 13, 2024
Impact of a health-system specialty pharmacy on time to upadacitinib initiation
David Choi, David T Rubin, Bernice Man
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
June 7, 2000
Temporal expression of the chondrogenic and angiogenic growth factor CYR61 during fracture repair
M Hadjiargyrou, W Ahrens, C T Rubin
Plos One
|
April 21, 2017
Indicators of suboptimal biologic therapy over time in patients with ulcerative colitis and Crohn's disease in the United States
Haridarshan Patel, Trevor Lissoos, David T Rubin
Inflammatory Bowel Diseases
|
February 24, 2012
Response to biologic therapy in Crohn's disease is improved with early treatment: an analysis of health claims data
David T Rubin, Ozgecan Uluscu, Robert Sederman
Page
of 79